Baker Brothers Advisors - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$1,907,298
-87.9%
106,197
-86.3%
0.01%
-87.9%
Q2 2023$15,782,294
-6.5%
775,9240.0%0.09%
-1.1%
Q1 2023$16,884,106
-29.8%
775,9240.0%0.09%
-36.1%
Q4 2022$24,045,885
+120.7%
775,924
+81.6%
0.14%
+102.8%
Q3 2022$10,897,000
+25.7%
427,1790.0%0.07%
+44.9%
Q2 2022$8,672,000
-17.9%
427,1790.0%0.05%
-19.7%
Q1 2022$10,568,000
-28.8%
427,1790.0%0.06%
-15.3%
Q4 2021$14,844,000
+28.1%
427,1790.0%0.07%
+41.2%
Q3 2021$11,585,000
+4.6%
427,1790.0%0.05%
+4.1%
Q2 2021$11,077,000
+20.3%
427,1790.0%0.05%
+22.5%
Q1 2021$9,206,000
+0.2%
427,1790.0%0.04%
+14.3%
Q4 2020$9,184,000
+27.8%
427,179
-12.3%
0.04%
+20.7%
Q3 2020$7,187,000
-37.4%
487,243
-5.1%
0.03%
-43.1%
Q2 2020$11,476,000
+246.2%
513,677
+119.0%
0.05%
+155.0%
Q1 2020$3,315,000
+80.4%
234,592
+107.4%
0.02%
+100.0%
Q4 2019$1,838,000
-53.6%
113,0860.0%0.01%
-63.0%
Q3 2019$3,957,000
-38.0%
113,0860.0%0.03%
-37.2%
Q2 2019$6,380,000
-22.8%
113,0860.0%0.04%
-18.9%
Q1 2019$8,261,000
+14.5%
113,0860.0%0.05%
-10.2%
Q4 2018$7,214,000
-36.1%
113,0860.0%0.06%
-20.3%
Q3 2018$11,283,000
+117.3%
113,086
+54.7%
0.07%
+89.7%
Q2 2018$5,192,000
-45.2%
73,086
-19.8%
0.04%
-51.2%
Q1 2018$9,480,000
-48.1%
91,086
-49.8%
0.08%
-49.4%
Q4 2017$18,269,000
+369.3%
181,386
+62.8%
0.16%
+393.8%
Q3 2017$3,893,000
+38.8%
111,386
-5.0%
0.03%
+28.0%
Q2 2017$2,805,000
-32.6%
117,211
-21.9%
0.02%
-26.5%
Q1 2017$4,163,000150,0000.03%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,950,609$35,032,9384.94%
EcoR1 Capital, LLC 7,521,024$135,077,5914.56%
Saturn V Capital Management LP 577,101$10,364,7344.34%
GREAT POINT PARTNERS LLC 894,333$16,062,2212.93%
5AM Venture Management, LLC 357,733$6,424,8851.85%
First Light Asset Management, LLC 790,806$14,202,8761.35%
Boxer Capital, LLC 1,300,000$23,348,0001.24%
Frazier Life Sciences Management, L.P. 899,700$16,158,6121.07%
Deep Track Capital, LP 1,345,813$24,170,8010.93%
Palo Alto Investors LP 431,224$7,744,7830.73%
View complete list of ANAPTYSBIO INC shareholders